WELCOME TO 90DAYRX.COM
90DAYRX.COM decodes as 90-day supply / mail-order—the duration patients and plans already associate with med-sync and retail-mail pharmacy. The Rx cue keeps it pharmacy-adjacent, not a random acronym.
Buyers: mail-order and retail-mail pharmacies; PBM med-sync programs; employer/plan enrollment microsites; and adherence vendors. Exact-fit launch: a “switch to 90-day” enrollment flow at 90DayRx.com with eligibility FAQ—duration brand 1stFill/1stDose do not own.
Market proof: ASHP reported U.S. prescription drug spending of $915 billion in 2025 (+12.7%), with a trajectory above $1 trillion in 2026.[1]
Why Choose 90DAYRX.COM
- Duration-exact: 90-day is plan and patient vernacular.
- Mail-order UX: Enrollment and refill-extension flows.
- Rx category lock: Pharmacy-adjacent without a molecule name.
- Vs 1stFill/1stDose: Supply length ≠pickup logistics ≠day-one education.
- $915B Rx spend: ASHP 2025 figure.[1]
- >$1T trajectory: 2026 outlook cited by ASHP.[1]
BUY NOW - $38,818
Buy Now — 90DAYRX.COM — lock this 90-day supply / mail-order door for pharmacy-aligned brands.
MAKE AN OFFERPurchase 90DAYRX.COM today through our trusted partners:
WHAT DOES ALBERT IGLES THINK?
"90DayRx.com is the duration door—mail-order and med-sync enrollment, not day-one onboarding."
Albert Igles, Domain Portfolio Manager
Contact Albert Igles via Email
FAQs
Who buys?
Mail-order pharmacies, PBM med-sync teams, and plan enrollment marketers.
Best first build?
A “switch to 90-day supply” enrollment microsite.
Vs 1stFill.com?
90-day duration/mail vs first-fill pickup logistics.
Figure?
ASHP: $915B U.S. Rx in 2025 (+12.7%).[1]
Contact Us
Feel free to contact us with any inquiries regarding 90DAYRX.COM; we’re here to help you secure this valuable asset.
Email: info@xeladomains.com
Phone: (858) 429-9352
Social Networks
Follow us on Instagram and LinkedIn for updates and more information about how 90DAYRX.COM can serve your business needs.
Instagram | LinkedIn